Erica L. Mayer, M.D. M.P.H.

Publications

• Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA.Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab.J Clin Oncol. 2011 Jan 4.
  21205755
• Curigliano G, Mayer EL, Burstein HJ, Winer EP, Goldhirsch A.Cardiac toxicity from systemic cancer therapy: a comprehensive review.Prog Cardiovasc Dis.;53(2):94-104. Review.
  20728696
• Mayer EL, Krop IE.Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.Clin Cancer Res. 2010 Jul 15;16(14):3526-32.
  20634194
• Mayer EL, Burstein HJ.Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer.J Clin Oncol. 2008 Mar 10;26(8):1198-200.
  18323544
• Mayer EL, Carey LA, Burstein HJ.Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.Breast Cancer Res. 2007;9(5):110.
  17888189
• Mayer EL, Burstein HJ.Chemotherapy for metastatic breast cancer.Hematol Oncol Clin North Am. 2007 Apr;21(2):257-72. Review.
  17512448
• Mayer EL, Lin NU, Burstein HJ.Novel approaches to advanced breast cancer: bevacizumab and lapatinib.J Natl Compr Canc Netw. 2007 Mar;5(3):314-23. Review.
  17439759